Being a part of a groundbreaking clinical trial put me on the path to recovery. I continue to eat healthy, exercise regularly and do my part to ensure my cancer does not return.
There is magic in the realization that the best of humanity is lifting you up, praying for you, holding you close, reaching out and touching your life in whatever way they can.
Here, a reader shares her experience with dealing with the side effects of hormonal therapy.
Anees B. Chagpar, director of the Breast Center at Smilow Cancer Hospital at Yale-New Haven, discusses what a patient can expect following a contralateral prophylactic mastectomy.
Marina Chiara Garassino, M.D., talks about how immunotherapy agents have vastly improved the treatment field of patients with non-small cell lung cancer.
Carolyn R. Aldige, founder and president of the Prevent Cancer Foundation, discusses the importance of cancer prevention.
Bob Dickey, a survivor of multiple myeloma, discusses the importance of the relationships formed when he and more than 80 other people climbed Mount Kilimanjaro.
The Leukemia & Lymphoma Society's (LLS) Clinical Trial Support Center helps patients with blood cancers find clinical trials that are right for them.
A PCF-funded study of men with prostate cancer in Italy suggests that men with prostate cancer who were taking ADT were 4 times less likely to be infected with the coronavirus than men who were not on ADT (androgen deprivation therapy), and 5 times less likely to die. These new findings are a game-changer and may lead to potential treatments for COVID-19, even in men without prostate cancer.
Naturally, newly diagnosed patients with multiple myeloma have a lot of questions for their physicians. Dr. Joshua Richter had the time to discuss some of them.
The extent of overdiagnosis in cancer differs according to the tumor type, its biology and the screening test.
As more treatment options become availabe in the cancer space, it may be difficult for patients and their caregivers to decide on the best plan of action. Maggie Row, M.D. offers her advice.
Everything about the words “breast cancer” is dark, sad and scary. When you add “metastatic” (stage 4) to those words, there comes an uncontrollable fear that encompasses the mind. To help people cope with this, four African American women started on a journey to educate women of color about the effects and importance of understanding breast cancer.
Danielle Nicosia, a survivor of thyroid cancer, discusses being misdiagnosed.
We've come a long way in determining which patients with prostate cancer to treat, but there is still more work that needs to be done.
Kurt Schroeder, a research nurse, pushes for a patient-first mentality, especially as they participate in a clinical trial.
An Extraordinary Healers essay honoring Kathryn “Kitty” Vance, RN, BSN [LCI Radiation Therapy in Pineville, North Carolina]
At CURE’s Educated Patient Summit on Multiple Myeloma Dr. Shebli Atrash had the chance to further discuss with CURE what questions he addresses most when patients with multiple myeloma undergo diagnostic testing.
An Extraordinary Healer essay honoring Carolyn Harshbarger, BSN, RN, OCN [ St. Vincent Health in Indianapolis, Indiana ]
My cancer diagnosis — and the emotional effects that came with it — made me who I am today.
An Extraordinary Healer essay honoring THERESA WILLIAMS, RN, OCN [SUMMIT CANCER CARE, SAVANNAH, GEORGIA]
Ashley Johnson, patient wellness navigator at Charleston Hematology and Oncology Associates, discusses how important it is for the whole health care team to better understand insurance and how patients pay for their cancer treatment.
Mark G. Malkin, M.D., professor of Neurology at the Virginia Commonwealth University, discusses the possibility of using viruses to treat glioblastoma.